A coming-of-age story: activation-induced cytidine deaminase turns 10 (original) (raw)

• Burnet, F.M. A modification of Jerne's theory of antibody production using the concept of clonal selection. CA Cancer J. Clin. 26, 119–121 (1976).
  CAS PubMed Google Scholar
• Lederberg, J. Genes and antibodies. Science 129, 1649–1653 (1959).
  CAS PubMed Google Scholar
• Weigert, M.G., Cesari, I.M., Yonkovich, S.J. & Cohn, M. Variability in the λ light chain sequences of mouse antibody. Nature 228, 1045–1047 (1970).
  CAS PubMed Google Scholar
• Crews, S., Griffin, J., Huang, H., Calame, K. & Hood, L. A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody. Cell 25, 59–66 (1981).
  CAS PubMed Google Scholar
• Selsing, E. & Storb, U. Somatic mutation of immunoglobulin light-chain variable-region genes. Cell 25, 47–58 (1981).
  CAS PubMed Google Scholar
• Tonegawa, S. Somatic generation of antibody diversity. Nature 302, 575–581 (1983).
  CAS PubMed Google Scholar
• Neuberger, M.S. Antibody diversification by somatic mutation: from Burnet onwards. Immunol. Cell Biol. 86, 124–132 (2008).
  CAS PubMed Google Scholar
• Schatz, D.G., Oettinger, M.A. & Baltimore, D. The V(D)J recombination activating gene, RAG-1. Cell 59, 1035–1048 (1989).
  CAS PubMed Google Scholar
• Oettinger, M.A., Schatz, D.G., Gorka, C. & Baltimore, D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517–1523 (1990).
  CAS PubMed Google Scholar
• Gellert, M.V. (D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71, 101–132 (2002).
  CAS PubMed Google Scholar
• Stavnezer, J., Guikema, J.E. & Schrader, C.E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26, 261–292 (2008).
  CAS PubMed PubMed Central Google Scholar
• Storb, U. et al. Targeting of AID to immunoglobulin genes. Adv. Exp. Med. Biol. 596, 83–91 (2007).
  PubMed Google Scholar
• Teng, G. & Papavasiliou, F.N. Immunoglobulin somatic hypermutation. Annu. Rev. Genet. 41, 107–120 (2007).
  CAS PubMed Google Scholar
• Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470–18476 (1999). Here, Honjo and colleagues report the cloning and initial characterization of AID.
  CAS PubMed Google Scholar
• Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553–563 (2000). This report describes the astonishing finding that AID-deficient animals lack both CSR and SHM; thus, AID is central to both secondary antibody-diversification reactions.
  CAS PubMed Google Scholar
• Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102, 565–575 (2000). Here, Durandy and colleagues demonstrate that a cohort of patients with hyper-IgM syndrome (who are deficient in CSR and SHM) have mutations in AID . Together with reference 13, this confirms the importance of AID in antibody diversification and disease.
  CAS PubMed Google Scholar
• Peters, A. & Storb, U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4, 57–65 (1996).
  CAS PubMed Google Scholar
• Wiesendanger, M., Scharff, M.D. & Edelmann, W. Somatic hypermutation, transcription, and DNA mismatch repair. Cell 94, 415–418 (1998).
  CAS PubMed Google Scholar
• Neuberger, M.S. et al. Monitoring and interpreting the intrinsic features of somatic hypermutation. Immunol. Rev. 162, 107–116 (1998).
  CAS PubMed Google Scholar
• Martin, A. & Scharff, M.D. Somatic hypermutation of the AID transgene in B and non-B cells. Proc. Natl. Acad. Sci. USA 99, 12304–12308 (2002).
  CAS PubMed PubMed Central Google Scholar
• Yoshikawa, K. et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033–2036 (2002).
  CAS PubMed Google Scholar
• Mayorov, V.I. et al. Expression of human AID in yeast induces mutations in context similar to the context of somatic hypermutation at G-C pairs in immunoglobulin genes. BMC Immunol. 6, 10 (2005).
  PubMed PubMed Central Google Scholar
• Poltoratsky, V.P., Wilson, S.H., Kunkel, T.A. & Pavlov, Y.I. Recombinogenic phenotype of human activation-induced cytosine deaminase. J. Immunol. 172, 4308–4313 (2004).
  CAS PubMed Google Scholar
• Petersen-Mahrt, S.K., Harris, R.S. & Neuberger, M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99–103 (2002). In this paper, Neuberger and colleagues demonstrate that ectopic overexpression of AID in bacteria increases the rate of mutation, which suggests that AID targets DNA.
  CAS PubMed Google Scholar
• Harris, R.S., Petersen-Mahrt, S.K. & Neuberger, M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247–1253 (2002).
  CAS PubMed Google Scholar
• Bransteitter, R., Pham, P., Scharff, M.D. & Goodman, M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100, 4102–4107 (2003).
  CAS PubMed PubMed Central Google Scholar
• Chaudhuri, J. et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726–730 (2003).
  CAS PubMed Google Scholar
• Dickerson, S.K., Market, E., Besmer, E. & Papavasiliou, F.N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197, 1291–1296 (2003). Together, references 26–28 show that AID is an active DNA deaminase that uses single-stranded DNA as its substrate.
  CAS PubMed PubMed Central Google Scholar
• Besmer, E., Market, E. & Papavasiliou, F.N. The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination. Mol. Cell. Biol. 26, 4378–4385 (2006).
  CAS PubMed PubMed Central Google Scholar
• Shen, H.M. et al. The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription. J. Exp. Med. 206, 1057–1071 (2009).
  CAS PubMed PubMed Central Google Scholar
• Nonaka, T. et al. Carboxy-terminal domain of AID required for its mRNA complex formation in vivo. Proc. Natl. Acad. Sci. USA 106, 2747–2751 (2009).
  CAS PubMed PubMed Central Google Scholar
• Pham, P., Bransteitter, R., Petruska, J. & Goodman, M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424, 103–107 (2003).
  CAS PubMed Google Scholar
• Yu, K., Huang, F.T. & Lieber, M.R. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279, 6496–6500 (2004).
  CAS PubMed Google Scholar
• Rogozin, I.B. & Diaz, M. Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. J. Immunol. 172, 3382–3384 (2004).
  CAS PubMed Google Scholar
• Nambu, Y. et al. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302, 2137–2140 (2003).
  CAS PubMed Google Scholar
• Vuong, B. et al. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat. Immunol. 10, 420–426 (2009).
  CAS PubMed PubMed Central Google Scholar
• Rada, C. et al. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12, 1748–1755 (2002).
  CAS PubMed Google Scholar
• Imai, K. et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4, 1023–1028 (2003).
  CAS PubMed Google Scholar
• Durandy, A., Revy, P. & Fischer, A. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). Adv. Immunol. 82, 295–330 (2004).
  CAS PubMed Google Scholar
• Begum, N.A. et al. Further evidence for involvement of a noncanonical function of uracil DNA glycosylase in class switch recombination. Proc. Natl. Acad. Sci. USA 106, 2752–2757 (2009).
  CAS PubMed PubMed Central Google Scholar
• Shivarov, V., Shinkura, R. & Honjo, T. Dissociation of in vitro DNA deamination activity and physiological functions of AID mutants. Proc. Natl. Acad. Sci. USA 105, 15866–15871 (2008).
  CAS PubMed PubMed Central Google Scholar
• Faili, A. et al. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat. Immunol. 3, 815–821 (2002).
  CAS PubMed Google Scholar
• Yadav, A. et al. Identification of a ubiquitously active promoter of the murine activation-induced cytidine deaminase (AICDA) gene. Mol. Immunol. 43, 529–541 (2006).
  CAS PubMed Google Scholar
• Crouch, E.E. et al. Regulation of AID expression in the immune response. J. Exp. Med. 204, 1145–1156 (2007).
  CAS PubMed PubMed Central Google Scholar
• Gonda, H. et al. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 198, 1427–1437 (2003).
  CAS PubMed PubMed Central Google Scholar
• Dedeoglu, F., Horwitz, B., Chaudhuri, J., Alt, F.W. & Geha, R.S. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFκB. Int. Immunol. 16, 395–404 (2004).
  Article CAS PubMed Google Scholar
• Park, S. et al. HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nat. Immunol. 10, 540–550 (2009).
  CAS PubMed PubMed Central Google Scholar
• Sayegh, C.E., Quong, M.W., Agata, Y. & Murre, C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4, 586–593 (2003).
  CAS PubMed Google Scholar
• Pauklin, S., Sernandez, I., Bachmann, G., Ramiro, A. & Petersen-Mahrt, S. Estrogen directly activates AID transcription and function. J. Exp. Med. 206, 99–111 (2009).
  CAS PubMed PubMed Central Google Scholar
• Gourzi, P., Leonova, T. & Papavasiliou, F.N. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24, 779–786 (2006).
  CAS PubMed Google Scholar
• Teng, G. et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28, 621–629 (2008).
  CAS PubMed PubMed Central Google Scholar
• Dorsett, Y. et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28, 630–638 (2008). Together, references 51 and 52 show that a specific mutation of a miR-155 target site present in the 3′ untranslated region of AID leads to deregulation of AID protein in transgenic or gene-targeted mice; therefore, miR155 directly regulates the amount of AID protein in vivo.
  CAS PubMed PubMed Central Google Scholar
• De Yebenes, V. et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205, 2199–2206 (2008).
  CAS PubMed PubMed Central Google Scholar
• Hunter, T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730–738 (2007).
  CAS PubMed Google Scholar
• Basu, U., Chaudhuri, J., Phan, R.T., Datta, A. & Alt, F.W. Regulation of activation induced deaminase via phosphorylation. Adv. Exp. Med. Biol. 596, 129–137 (2007).
  PubMed Google Scholar
• Mcbride, K. et al. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 205, 2585–2594 (2008).
  CAS PubMed PubMed Central Google Scholar
• Cheng, H. et al. Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice. Proc. Natl. Acad. Sci. USA 106, 2717–2722 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mcbride, K. et al. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 103, 8798–8803 (2006).
  CAS PubMed PubMed Central Google Scholar
• Aoufouchi, S. et al. Proteasomal degradation restricts the nuclear lifespan of AID. J. Exp. Med. 205, 1357–1368 (2008).
  CAS PubMed PubMed Central Google Scholar
• Delker, R. & Papavasiliou, F. Elucidating the mechanism of specificity achieved by activation-induced cytidine deaminase. Keystone Meeting, Taos, NM (2009).
  Google Scholar
• Li, M. et al. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972–1975 (2003).
  CAS PubMed Google Scholar
• Ito, S. et al. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 101, 1975–1980 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mcbride, K. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199, 1235–1244 (2004).
  CAS PubMed PubMed Central Google Scholar
• Brar, S., Watson, M. & Diaz, M. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279, 26395–26401 (2004).
  CAS PubMed Google Scholar
• Durandy, A., Revy, P., Imai, K. & Fischer, A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol. Rev. 203, 67–79 (2005).
  CAS PubMed Google Scholar
• Ta, V.T. et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 4, 843–848 (2003).
  CAS PubMed Google Scholar
• Patenaude, A. et al. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat. Struct. Mol. Biol. 16, 517–527 (2009).
  CAS PubMed Google Scholar
• Ramiro, A.R., Stavropoulos, P., Jankovic, M. & Nussenzweig, M.C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4, 452–456 (2003).
  CAS PubMed Google Scholar
• Shen, H.M. & Storb, U. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc. Natl. Acad. Sci. USA 101, 12997–13002 (2004).
  CAS PubMed PubMed Central Google Scholar
• Okazaki, I.M. et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197, 1173–1181 (2003).
  CAS PubMed PubMed Central Google Scholar
• Yoshikawa, K. AID Enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033–2036 (2002).
  CAS PubMed Google Scholar
• Liu, M. et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451, 841–845 (2008).
  CAS PubMed Google Scholar
• Lebecque, S.G. & Gearhart, P.J. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1 kb from V(D)J gene. J. Exp. Med. 172, 1717–1727 (1990).
  CAS PubMed Google Scholar
• Fukita, Y., Jacobs, H. & Rajewsky, K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity 9, 105–114 (1998).
  CAS PubMed Google Scholar
• Tumas-Brundage, K. & Manser, T. The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J. Exp. Med. 185, 239–250 (1997).
  CAS PubMed PubMed Central Google Scholar
• Winter, D.B., Sattar, N., Mai, J.J. & Gearhart, P.J. Insertion of 2 kb of bacteriophage DNA between an immunoglobulin promoter and leader exon stops somatic hypermutation in a kappa transgene. Mol. Immunol. 34, 359–366 (1997).
  CAS PubMed Google Scholar
• Rada, C. & Milstein, C. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially. EMBO J. 20, 4570–4576 (2001).
  CAS PubMed PubMed Central Google Scholar
• Rajagopal, D. et al. Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation. J. Exp. Med. 206, 1237–1244 (2009).
  CAS PubMed PubMed Central Google Scholar
• Shen, H.M., Peters, A., Kao, D. & Storb, U. The 3′ Igκ enhancer contains RNA polymerase II promoters: implications for endogenous and transgenic kappa gene expression. Int. Immunol. 13, 665–674 (2001).
  CAS PubMed Google Scholar
• Yang, S., Fugmann, S. & Schatz, D. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences. J. Exp. Med. 203, 2919–2928 (2006).
  CAS PubMed PubMed Central Google Scholar
• Yang, S. & Schatz, D. Targeting of AID-mediated sequence diversification by cis-acting determinants. Adv. Immunol. 94, 109–125 (2007).
  CAS PubMed Google Scholar
• Odegard, V.H. & Schatz, D.G. Targeting of somatic hypermutation. Nat. Rev. Immunol. 6, 573–583 (2006).
  CAS PubMed Google Scholar
• Goyenechea, B. et al. Cells strongly expressing Igκ transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J. 16, 3987–3994 (1997).
  CAS PubMed PubMed Central Google Scholar
• Betz, A.G. et al. Elements regulating somatic hypermutation of an immunoglobulin κ gene: critical role for the intron enhancer/matrix attachment region. Cell 77, 239–248 (1994).
  CAS PubMed Google Scholar
• Perlot, T., Alt, F., Bassing, C.H., Suh, H. & Pinaud, E. Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc. Natl. Acad. Sci. USA 102, 14362–14367 (2005).
  CAS PubMed PubMed Central Google Scholar
• Inlay, M.A. et al. Roles of the Ig κ light chain intronic and 3′ enhancers in Igk somatic hypermutation. J. Immunol. 177, 1146–1151 (2006).
  CAS PubMed Google Scholar
• Wuerffel, R. et al. S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. Immunity 27, 711–722 (2007).
  CAS PubMed PubMed Central Google Scholar
• Kothapalli, N., Norton, D.D. & Fugmann, S.D. Cutting edge: a cis-acting DNA element targets AID-mediated sequence diversification to the chicken Ig light chain gene locus. J. Immunol. 180, 2019–2023 (2008).
  CAS PubMed Google Scholar
• Blagodatski, A. et al. A cis-acting diversification activator both necessary and sufficient for AID-mediated hypermutation. PLoS Genet. 5, e1000332 (2009). References 88 and 89 identify a mutational enhancer at the chicken Igl locus that is distinct from known enhancers and can confer mutability to heterologous genes; this is the first demonstration that an AID-catalyzed mutation is specifically 'recruited' to the immunoglobulin locus.
  PubMed PubMed Central Google Scholar
• Michael, N. et al. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19, 235–242 (2003).
  CAS PubMed Google Scholar
• Schoetz, U., Cervelli, M., Wang, Y.D., Fiedler, P. & Buerstedde, J.M. E2A expression stimulates Ig hypermutation. J. Immunol. 177, 395–400 (2006).
  CAS PubMed Google Scholar
• Basu, U. et al. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438, 508–511 (2005).
  CAS PubMed Google Scholar
• Chaudhuri, J., Khuong, C. & Alt, F. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430, 992–998 (2004). References 93 and 94 offer the first demonstration of a specific post-translational modification of AID (Ser38 phosphorylation), as well as the identification of the first putative AID cofactor (RPA) whose interaction depends on this modification.
  CAS PubMed Google Scholar
• Schramke, V. et al. RPA regulates telomerase action by providing Est1p access to chromosome ends. Nat. Genet. 36, 46–54 (2004).
  CAS PubMed Google Scholar
• Conticello, S. et al. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Mol. Cell 31, 474–484 (2008).
  CAS PubMed Google Scholar
• Hein, K. et al. Processing of switch transcripts is required for targeting of antibody class switch recombination. J. Exp. Med. 188, 2369–2374 (1998).
  CAS PubMed PubMed Central Google Scholar
• Gomez-Gonzalez, B. & Aguilera, A. Activation-induced cytidine deaminase action is strongly stimulated by mutations of the THO complex. Proc. Natl. Acad. Sci. USA 104, 8409–8414 (2007).
  CAS PubMed PubMed Central Google Scholar
• Li, X. & Manley, J.L. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122, 365–378 (2005).
  CAS PubMed Google Scholar
• Reddy, K.L., Zullo, J.M., Bertolino, E. & Singh, H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 452, 243–247 (2008).
  CAS PubMed Google Scholar
• Gartenberg, M.R. Life on the edge: telomeres and persistent DNA breaks converge at the nuclear periphery. Genes Dev. 23, 1027–1031 (2009).
  CAS PubMed PubMed Central Google Scholar
• Oza, P., Jaspersen, S.L., Miele, A., Dekker, J. & Peterson, C.L. Mechanisms that regulate localization of a DNA double-strand break to the nuclear periphery. Genes Dev. 23, 912–927 (2009).
  CAS PubMed PubMed Central Google Scholar
• Schober, H., Ferreira, H., Kalck, V., Gehlen, L.R. & Gasser, S.M. Yeast telomerase and the SUN domain protein Mps3 anchor telomeres and repress subtelomeric recombination. Genes Dev. 23, 928–938 (2009).
  CAS PubMed PubMed Central Google Scholar
• Nagai, S. et al. Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science 322, 597–602 (2008).
  CAS PubMed PubMed Central Google Scholar
• Geisberger, R., Rada, C. & Neuberger, M. The stability of AID and its function in class-switching are critically sensitive to the identity of its nuclear-export sequence. Proc. Natl. Acad. Sci. USA 106, 6736–6741 (2009).
  CAS PubMed PubMed Central Google Scholar
• Dunnick, W. et al. Switch Recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region. J. Exp. Med. (in the press).